ViaCell
ViaCord is dedicated to helping families plan for their future health through cord blood and tissue banking, DNA testing, and health insights. With over 30 years of experience, they provide a range of services including stem cell banking for newborns and adults, genetic testing, and ongoing research into regenerative medicine and treatments for conditions like autism, cerebral palsy, and congenital heart defects. They also promote healthy pregnancy practices, sleep habits, and the potential of stem cell therapy for various conditions.
Industries
Nr. of Employees
small (1-50)
ViaCell
Boston, Massachusetts, United States, North America
Products
Information kit (PDF)
Downloadable informational kit summarizing cord blood/tissue banking services, testing options and frequently asked questions for expectant families.
Information kit (PDF)
Downloadable informational kit summarizing cord blood/tissue banking services, testing options and frequently asked questions for expectant families.
Services
Collection, processing and long-term cryostorage of newborn cord blood units containing hematopoietic stem cells for potential future transplant or investigational use.
Collection and cryopreservation of umbilical cord tissue as a source of mesenchymal-like cells and extracellular matrix for investigational regenerative-medicine applications.
Whole-genome sequencing of newborn samples performed through a contracted CLIA laboratory with analysis for childhood-onset conditions and medication-sensitivity variants.
Laboratory testing using targeted multi-gene panels for actionable, childhood-onset conditions and trait predispositions, delivered via CLIA-certified partner laboratories.
Isolation and long-term storage of a high-quality DNA aliquot from a newborn specimen to enable future genomic testing without repeat sampling.
Whole-genome sequencing service for adults, delivered via contracted CLIA laboratory, including analysis for adult-onset conditions and pharmacogenomic variants.
Collection, processing and long-term cryostorage of newborn cord blood units containing hematopoietic stem cells for potential future transplant or investigational use.
Collection and cryopreservation of umbilical cord tissue as a source of mesenchymal-like cells and extracellular matrix for investigational regenerative-medicine applications.
Whole-genome sequencing of newborn samples performed through a contracted CLIA laboratory with analysis for childhood-onset conditions and medication-sensitivity variants.
Laboratory testing using targeted multi-gene panels for actionable, childhood-onset conditions and trait predispositions, delivered via CLIA-certified partner laboratories.
Isolation and long-term storage of a high-quality DNA aliquot from a newborn specimen to enable future genomic testing without repeat sampling.
Whole-genome sequencing service for adults, delivered via contracted CLIA laboratory, including analysis for adult-onset conditions and pharmacogenomic variants.
Expertise Areas
- Biobanking and cryopreservation
- Clinical supply chain and chain-of-custody for cellular therapies
- Genomic sequencing and clinical variant interpretation
- Regenerative medicine research partnerships and clinical-trial support
Key Technologies
- Cryogenic storage and controlled-rate freezing
- Cell processing for hematopoietic and mesenchymal stem cells
- Whole-genome sequencing (WGS)
- Targeted multi-gene panel sequencing
News & Updates
ViaCord has released over 500 cord blood units for clinical treatments and 100 units for autism spectrum disorder, marking significant milestones in their contribution to regenerative medicine and treatment options.
An article discussing how supporting heart health during pregnancy can benefit both mother and baby, emphasizing healthy habits and medical monitoring.
Guidance on soothing techniques such as swaddling, sounds, rhythmic movements, bath time, and quiet time to help calm fussy infants.
Research indicating that birth month and epigenetic marks influence allergy risks, with insights into DNA methylation and gene expression.
Exploration of how fetal stem cells can remain in a mother's body for years after childbirth, potentially aiding in healing and health benefits.
An article discussing how birth month and epigenetic marks influence allergy risks, with insights into DNA methylation and gene expression.
ViaCord has released over 500 cord blood units for clinical treatments and 100 units for autism spectrum disorder, marking significant milestones in their contribution to regenerative medicine and treatment options.
An article discussing how supporting heart health during pregnancy can benefit both mother and baby, emphasizing healthy habits and medical monitoring.
Guidance on soothing techniques such as swaddling, sounds, rhythmic movements, bath time, and quiet time to help calm fussy infants.
Research indicating that birth month and epigenetic marks influence allergy risks, with insights into DNA methylation and gene expression.
Exploration of how fetal stem cells can remain in a mother's body for years after childbirth, potentially aiding in healing and health benefits.
An article discussing how birth month and epigenetic marks influence allergy risks, with insights into DNA methylation and gene expression.